Regenxbio (RGNX) Receivables - Other (2014 - 2026)
Regenxbio (RGNX) posted quarterly Receivables - Other of $10.9 million for Q4 2025, down 3.57% year-over-year from $11.3 million in Q4 2024, and down 52.11% quarter-over-quarter from $22.8 million in Q3 2025.
Regenxbio (RGNX) Receivables - Other (2014 - 2026) Analysis & Trends
Regenxbio's Receivables - Other history runs 10 years deep, the most recent figure standing at $10.9 million for Q4 2025.
- In Q4 2025, Receivables - Other fell 3.57% year-over-year to $10.9 million; the TTM figure through Dec 2025 stood at $10.9 million (down 3.57% YoY), while the FY2025 annual figure was $10.9 million, down 45.79% from the prior year.
- Receivables - Other for Q4 2025 stood at $10.9 million, down from $22.8 million in the prior quarter.
- The five-year high for Receivables - Other was $33.5 million in Q2 2022, with the low at $28000.0 in Q2 2025.
- The 5-year median for Receivables - Other is $5.6 million (2022), against an average of $10.8 million.
- Peak annual rise in Receivables - Other reached 8688.03% in 2025, while the deepest fall reached 99.71% in 2025.
- Regenxbio's Receivables - Other stood at $1.1 million in 2021, then jumped by 486.03% to $6.3 million in 2022, then declined by 20.56% to $5.0 million in 2023, then jumped by 126.08% to $11.3 million in 2024, then slipped by 3.57% to $10.9 million in 2025.
- Business Quant data shows RGNX's Receivables - Other at $10.9 million in Q4 2025, $22.8 million in Q3 2025, and $28000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.54 Mn |
| Jun 30, 2026 | 10.54 Mn |
| Dec 31, 2025 | 10.90 Mn |
| Dec 31, 2025 | 10.90 Mn |
| Sep 30, 2025 | 22.76 Mn |
| Sep 30, 2025 | 22.76 Mn |
| Jun 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Dec 31, 2024 | 11.30 Mn |
| Dec 31, 2024 | 11.30 Mn |
| Sep 30, 2024 | 259,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Jun 30, 2024 | 194,000.00 |
| Jun 30, 2024 | 194,000.00 |
| Mar 31, 2024 | 15.31 Mn |
| Mar 31, 2024 | 15.31 Mn |
| Dec 31, 2023 | 5.00 Mn |
| Dec 31, 2023 | 5.00 Mn |